Seikagaku Corporation (TYO:4548)
617.00
-4.00 (-0.64%)
Jun 20, 2025, 3:30 PM JST
Seikagaku Revenue
In the fiscal year ending March 31, 2025, Seikagaku had annual revenue of 39.37B JPY with 8.73% growth. Seikagaku had revenue of 8.93B in the quarter ending March 31, 2025, with 1.13% growth.
Revenue
39.37B
Revenue Growth
+8.73%
P/S Ratio
0.86
Revenue / Employee
36.63M
Employees
1,075
Market Cap
33.67B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 39.37B | 3.16B | 8.73% |
Mar 31, 2024 | 36.21B | 2.76B | 8.24% |
Mar 31, 2023 | 33.46B | -1.40B | -4.00% |
Mar 31, 2022 | 34.85B | 7.19B | 25.99% |
Mar 31, 2021 | 27.66B | -980.00M | -3.42% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |